THIS CONTENT IS INTENDED FOR HEALTHCARE PROFESSIONALS

IN ORDER TO BREAK DOWN BARRIERS, WE NEED TO TALK ABOUT WHAT THEY ARE. 

Pfizer is committed to changing the conversation in advanced prostate cancer (aPC) by shining a light on inequities in care and exploring the causes behind them.

SHARE THE VIDEO TO GET OTHERS TALKING ABOUT EQUITY IN aPC CARE. ​​​​​​​

SHARE
rectangle

HOW PFIZER IS CHANGING THE
CONVERSATION AROUND EQUITY IN
ADVANCED PROSTATE CANCER

With many racial and ethnic minority groups underrepresented in prostate cancer research, Pfizer published a call-to-action in the journal CANCER to researchers and drug developers to improve diversity in clinical trials.
To ensure people of all backgrounds have their voices heard in the prostate cancer conversation, we are providing support as founding sponsors for programs that allow patient authors to present research at conferences like the 2022 American Urological Association Annual Meeting and the 35th and 36th Annual European Association of Urology congresses.
To help reduce health literacy disparities and improve education among patients, we developed more than 450 summaries of scientific publications in plain, patient-friendly language.
By analyzing large claims databases and looking at how prostate cancer treatments are used in the real world, we are identifying disparities in treatment associated with poverty and race.

How Health Literacy Affects Equitable Care in Advanced Prostate Cancer

LEARN MORE

OUR PROGRAMS

This Is Living With Cancer™ 
This Is Living With Cancer is a comprehensive program from Pfizer Oncology to support people in their cancer journey, with a growing focus on underserved communities who experience challenges in access to care, such as: people living with cancer over the age of 65, racial and ethnic minorities, those of lower income, or individuals who live in rural areas who may not have equal access to resources.
​​​​​​Boldly Caring™
The Boldly Caring program offers resources for patients and their caregivers to help navigate an advanced prostate cancer diagnosis and advocate for the best care possible.

COLLABORATION IS
KEY TO CHANGING
THE CONVERSATION.  

With a long-standing dedication to research and treatment, we are creating partnerships to promote equitable care for everyone with advanced prostate cancer, no matter who they are or where they live. In collaboration with the American Cancer Society, we’ve awarded six grants for local health system quality improvement projects aimed at reducing disparities among Black men in prostate cancer care.  

Additionally, we have collaborated with the Prostate Cancer Foundation to award 11 grants to support prostate cancer research initiatives globally. These awards support research projects that improve the understanding of, or reduce disparities in the diagnosis, treatment, and outcomes of, patients in minority and underserved communities.
Collaboration is KeyThe American Cancer Society
THE AMERICAN CANCER SOCIETY®
The American Cancer Society funds research, provides information, and offers support services for anyone living with cancer.
Prostate Cancer Foundation
PROSTATE CANCER FOUNDATION
PCF funds research to improve the prevention, detection, and treatment of prostate cancer.
Rectangle

PFIZER IS COMMITTED TO
ADVANCING HEALTH EQUITY

We are working hand-in-hand with
​​​​​​​the community in three key focus areas:

PARTNERING WITH
COMMUNITIES

The Pfizer Multicultural Health Equity Collective engages over 40 organizations to improve health equity across ethnic groups and other underrepresented communities facing significant health disparities.

Rectangle

DIVERSITY IN CLINICAL TRIALS

Pfizer’s Diversity in Clinical Trials Center of Excellence supports clinical trial teams in meeting diversity goals by:

  • Encouraging early consideration of diverse representation in study designs
  • Establishing diversity goals at a study level that are driven by real-world data, medical literature, and census data
  • Leveraging technology to assist with recruitment in underrepresented communities
  • Real-time monitoring of diverse enrollment at study and investigator site levels
Rectangle

DISEASE AWARENESS

Educating communities about a variety of disease states, including oncology.

LEARN MORE

NAVIGATE

CCinPC Logo
Pfizer Logo
This site is intended only for U.S. residents. The information provided is for educational
purposes only and is not intended to replace discussions with a healthcare provider.
PP-UNP-USA-0312
​​​​​​​Copyright © 2002-2022 Pfizer Inc. All rights reserved.